INTRODUCTION {#s1}
============

Acute kidney injury (AKI) is increasingly common and associated with adverse clinical outcomes, including excess mortality and morbidity, and prolonged hospital length of stay (LOS) \[[@R1]--[@R4]\]. Renal replacement therapy (RRT) is the cornerstone for the treatment of severe AKI. Although RRT provokes a considerable escalation in the complexity of therapy, the optimal timing of initiation of RRT in patients with AKI has been the focus of those debates \[[@R5], [@R6]\]. Conflicting results from clinical trials and systematic reviews have not resolved the debates, leaving clinicians to select the timing of initiation of RRT based on suboptimal evidence.

Studies aimed at determining the optimal time for starting RRT have evaluated the various arbitrary cut-offs for time from Intensive Care Unit (ICU) admission \[[@R7]--[@R9]\] or development of a biochemical "start time" \[[@R10], [@R11]\], AKI stage \[[@R12], [@R13]\], serum urea \[[@R14], [@R15]\], urine output \[[@R16], [@R17]\], fluid balance \[[@R18]\], and serum creatinine \[[@R15], [@R19], [@R20]\]. However, the arbitrary cut-offs often differentiated between early and late RRT. Some data suggested that early compared with late RRT reduced the mortality with better renal recovery. Early initiation of RRT may produce benefits by avoiding hypervolemia, eliminating of uremic toxins, establishing acid-base homeostasis, and preventing other complications such as gastric hemorrhage and metabolic encephalopathy \[[@R7], [@R13], [@R16]\]. Late RRT may allow time for the stabilization of a patient's condition before RRT and may even avoid the RRT \[[@R12], [@R21]--[@R23]\]. Gaudry et al. showed that the mortality was lower in patients who never received RRT than those received RRT early or late (37.1% vs. 48.5% or 61.8%), and the patients with late RRT were the most severely ill at baseline \[[@R13]\]. Thus, we hypothesized that the different severity of illness for patients with AKI who received early RRT may produce distinct effects on mortality. Therefore, we firstly performed a meta-analysis according to the severity of illness for patients with AKI to investigate the opportunity of RRT initiation.

3 earlier meta-analyses (Seabra et al. \[[@R24]\] identified 23 studies, Karvellas et al. \[[@R25]\] identified 15 studies and Wang et al. \[[@R26]\] included 51 trials) showed that early RRT could confer a survival benefit. 11 trials performed before 1985 in Seabra et al. and Wang et al. were excluded, and the addition of 10 recently published studies have been included in the present meta-analysis. However, a recent meta-analysis found no significant difference in mortality between early and late RRT \[[@R27]\], but included only nine "high-quality" studies. Furthermore, the included studies were limited with high heterogeneity. In the present study, we firstly made a definition of early RRT based on time-based cutoffs for patients with AKI to investigate the optimal timing of initiation of RRT.

RESULTS {#s2}
=======

Study enrolment and characteristics {#s2_1}
-----------------------------------

Figure [1](#F1){ref-type="fig"} outlines the process for study selection. 49 studies including 9 RCTs \[[@R10], [@R12], [@R13], [@R15], [@R16], [@R19], [@R21]--[@R23]\] and 40 observational studies \[[@R7]--[@R9], [@R11], [@R14], [@R17], [@R18], [@R20], [@R28]--[@R59]\] were included in our meta-analysis. The eligible studies were conducted from 1985 to 2016 with 9698 patients evaluated the timing of initiation of RRT in patients with AKI. The characteristics of the articles were listed in Table [1](#T1){ref-type="table"}, and the details of risk of bias for RCTs were showed in Figure [2](#F2){ref-type="fig"}.

![Flow diagram for the selection of studies inclusion in the meta-analysis](oncotarget-08-68795-g001){#F1}

###### The fundamental characteristics and patient demographic data of included studies reporting data on early RRT versus late RRT

  Auther, Year                                                                                Country          Study Design    Population                        Early Mortality   Late Mortality   Severity ofIllness                               Early RRT Criteria                                                                                                                Late RRT Criteria                                                                                       Quality
  ------------------------------------------------------------------------------------------- ---------------- --------------- --------------------------------- ----------------- ---------------- ------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ---------
  Early time to RRT \<12 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Bouman2002                                                                                  Netherlands      RCT             Multisystem                       20/70             9/36             Early: SOFA 10.3;Late: SOFA 10.6                 Time to RRT\<12 h                                                                                                                 Time to RRT\>12h                                                                                        M
  Piccinni2006                                                                                Italy            Retrospective   Sepsis; ICU                       18/40             29/40            Early: APACHE2=27.2;Late: APACHE2=27.8           Time to RRT \<12 h                                                                                                                No RRT                                                                                                  7
  Andrade2007                                                                                 Brazil           Retrospective   Multisystem;Leptospirosis         3/18              10/15            Early: APACHE2=24.5;Late: APACHE2=26             Mean time to RRT = 4.4hrs                                                                                                         Mean time to RRT = 27.3hrs                                                                              5
  Wu VC2007                                                                                   China            Retrospective   Acute LiverFailure;Surgical ICU   34/54             22/26            Early: APACHE2=18;Late: APACHE2=19               Mean time from ICU admit to RRT =4.4hrs; BUN\<80 mg/dL ANDtraditional indications present                                         Mean time from ICU admit to RRT =11.1hrs; BUN\>80 mg/dL ANDtraditional indications present              6
  Manche2008                                                                                  Malta            Retrospective   Post CardiacSurgery               14/56             13/15            NR                                               Mean RRT start 8.6hrs post-op; Oliguria unresponsive to med mgmt                                                                  Mean RRT start 41.2hrs post-op; Oliguria refractory to med mgmt                                         6
  Ji2011                                                                                      China            Retrospective   Post CardiacSurgery               3/34              9/24             Early: APACHE3= 69;Late: APACHE3= 88.2p\<0.001   Time from urine output \<0.5ml/kg/h to RRT \<12h; Mean oliguria to start of RRT 8.4hrs                                            Time from urine output \<0.5ml/kg/h to RRT \>12h; Mean oliguria to start of RRT21.5hrs                  6
  Shum2013                                                                                    China            Retrospective   Multisystem;Sepsis                43/89             15/31            Early: SOFA 13;Late: SOFA 12P=0.011              Mean time from ICU admit to RRT= 10.8hrs (RIFLE criteria:'Injury' or 'Failure' criteria)                                          Mean time from ICU admit to RRT =20.7hrs (RIFLE criteria:'pre- Risk' or 'Risk' criteria)                6
  Serpytis2014                                                                                Lithuania        Retrospective   Multisystem;Sepsis                30/42             39/43            NR                                               Time from anuria to RRT \<12hrs                                                                                                   Time from anuria to RRT \>12hrs                                                                         5
  Wald2015                                                                                    Canada           RCT             Multisystem                       16/48             19/52            Early: SOFA 13.3;Late: SOFA 12.8                 Mean time to RRT = 9.7hrs                                                                                                         Meantime to RRT = 32hrs;Classic indications for RRT                                                     H
  Crescenzi2015                                                                               Italy            Prospective     Post CardiacSurgery               28/46             10/13            NR                                               Time from urine output \<0.5ml/kg/hto RRT \<12h                                                                                   Time from urine output \<0.5ml/kg/h to RRT \>12h                                                        6
  Zarbock2015                                                                                 Germany          RCT             Multisystem                       44/112            65/119           Early: SOFA 15.6;Late: SOFA 16.0                 Time to RRT \<8h; KDIGO stage 2                                                                                                   Time to RRT \<12h; Stage 3 AKIor no initiation                                                          H
  Gaudry2015                                                                                  France           RCT             Multisystem                       150/311           153/308          Early: SOFA 10.9;Late: SOFA 10.8                 Time to RRT \<6h; Stage 3 AKI                                                                                                     Classic indications for RRT; Oliguria or anuria \>72hrs after randomization                             H
  Early time to RRT \<24 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Elahi2004                                                                                   UK               Retrospective   Post Cardiacsurgery               8/36              12/28            NR                                               Mean RRT start 0.78 days;Low urine output \<100ml within 8h after surgery                                                         Mean RRT start 2.5 days; Traditional indications: Urea≥30mmol/L, Cr ≥250mmol/L, K \>6.0mEq/L            6
  Demirkilic2004                                                                              Turkey           Retrospective   Post CardiacSurgery               8/34              15/27            NR                                               Mean RRT start 0.88 days;Low urine output \<100ml within 8hrs post-op;                                                            Mean RRT start 2.56 days;Cr ≥5mg/dL, or K \>5.5 mEq/L                                                   6
  Boussekey2012                                                                               France           Retrospective   Multisystem                       28/67             28/43            Early: SOFA: 11.1;Late: SOFA 8.8;p=0.002         Time from RIFLE- 'Injury' to RRT\< 16hrs; Mean time to RRT=6hrs                                                                   Time from RIFLE- 'Injury' to RRT \> 16hrs; Mean time to RRT=64hrs                                       7
  Chon2012                                                                                    Korea            Retrospective   Multisystem;Sepsis                7/36              9/19             Early: SOFA 13.5;Late: SOFA 12                   Time to RIFLE 'Injury'/'Failure'\< 24hrs; Mean time to RRT=12.5hrs                                                                Time to RIFLE 'Injury'/'Failure'\> 24hrs; Mean time to RRT= 42.2hrs                                     7
  Leite2013                                                                                   Brazil           Retrospective   Multisystem                       33/64             67/86            Early: APACHE2=19.2;Late: APACHE2=18.7           Time from AKIN 3 diagnosis to RRT \<24hrs                                                                                         Time from AKIN 3 diagnosis to RRT \>24hrs                                                               7
  Jun2014                                                                                     Australia        Prospective     Multisystem;Sepsis                82/219            84/220           Early: SOFA: 2.0;Late: SOFA 2.1                  Time from AKI diagnosis to RRT \<17.6hrs                                                                                          Time from AKI diagnosis to RRT\>17.6hrs                                                                 6
  Combes2015                                                                                  France           RCT             Post CardiacSurgery               40/112            40/112           Early: SOFA 11.5;Late: SOFA 12.0                 RRT initiated \<24hrs and continuedfor min of 48hrs                                                                               Traditional indications for RRT                                                                         H
  Yang2016                                                                                    China            Retrospective   Post CardiacSurgery               20/59             80/154           Early: APACHE2=21.4.;Late: APACHE2=23.1          AKI in absence of traditional indications for RRT; persistence of hypotension (for more than 6 h) despite preload optimization;   Traditional indications for RRT                                                                         7
  Early time to RRT \<48 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Durmaz2003                                                                                  Turkey           RCT             Post CardiacSurgery               1/21              7/23             NR                                               Cr rise \>10% from pre-op levelwithin 48hrsof surgery                                                                             Cr rise \>50%from pre-op level;or Urine output \<400ml/24hrs                                            L
  Lyem2009                                                                                    Turkey           Prospective     Post CardiacSurgery               5/95              6/90             NR                                               Low urine output triggering RRT started \<48hrs; Evidence of 50% increase in BUN,                                                 Time \>48hrs to start of RRT for similar markers of renal failure managed medically for minimum 48hrs   7
  Bagshaw2009                                                                                 Multicountries   Prospective     Multisystem                       462/785           304/442          Early: SOFA 10.9;Late: SOFA 10.7p=0.04           RRT started \<2d from ICU admission                                                                                               RRT started \>2d from ICU admission                                                                     7
  Perez2012                                                                                   Spain            Prospective     MultisystemSepsis                 71/135            78/109           Early: SOFA 12;Late: SOFA 11                     Time from ICU admission to RRT \< 48h                                                                                             Time from ICU admission to RRT \> 48h                                                                   5
  Lim2014                                                                                     Singapore        Prospective     Multisystem                       37/56             36/84            Early: SOFA 11;Late: SOFA 7;p=0.001              RRT started \< 2d from admission;Traditional indications for RRT                                                                  RRT started \> 2d from admission; AKIN stage 1 or 2 with indication or AKIN stage3                      6
  Hyung2016                                                                                   Korea            Retrospective   MultisystemSepsis                 9/30              17/30            Early: APACHE2=22.9;Late: APACHE2=21.1           Time to RRT \<26.4 h                                                                                                              Time to RRT \>26.4 h                                                                                    6
  Early time to RRT \<72 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Sugahara2004                                                                                Japan            RCT             Post CardiacSurgery               12/14             2/14             Early: APACHE2=18;Late: APACHE2=19               Mean time to RRT start 1.7d±0.8 post op; UOP \<20ml/hrs ×2hrs + OR UOP \<500ml/day                                                Mean time to RRT start 18d±0.9 post op; UOP \<30ml/hrs ×3hrs ORUOP \<750ml/day                          L
  Sabater2009                                                                                 Spain            Prospective     Multisystem                       21/44             68/104           Early: APACHE2=26;Late: APACHE2=24               Mean RRT start 2.2d post ICU admit (RIFLE criteria: RISK & INJURY)                                                                Mean RRT start 6.4d post ICU admit (RIFLE criteria: FAILURE)                                            7
  Fernandez2011                                                                               Spain            Retrospective   Post CardiacSurgery               59/111            74/92            NR                                               RRT started \<3d after cardiac surgery                                                                                            RRT started \>3d after cardiac surgery                                                                  5
  Shiao2012                                                                                   China            Retrospective   Surgical                          236/436           143/212          Early: SOFA 11.4;Late: SOFA 11.3                 Time to development of traditional RRT indications \<3d; Mean time to start of RRT 1.4d                                           Traditional RRT indications AND start of RRT \>3 d; Mean time to start of RRT 18d                       6
  Early time to RRT \>72 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Gettings1999                                                                                USA              Retrospective   Multisystem;Trauma                25/41             47/59            Early ISS = 33.0;Late ISS = 37.2                 Mean RRT start post admission10d; BUN \<60mg/dl AND Oliguria, Vol overload, Electrolytes, Uremia;                                 Mean RRT start post admission 19d; BUN \>60 mg/dL AND Oliguria, Electrolytes, Uremia;                   5
  Shiao2009                                                                                   China            Prospective     MajorAbdominalSurgery             22/51             34/47            Early: SOFA 8.3;Late: SOFA 8.5                   Mean Time to RRT from ICU Admit =7.3d (RIFLE criteria:RISK or pre-RISK criteria)                                                  Mean Time to RRT from ICU Admit = 8.4d (RIFLE criteria:INJURY or FAILURE criteria)                      7
  Chung2009                                                                                   US               Retrospective   Severe BurnedPatients             9/29              24/28            Early: SOFA 13;Late: SOFA 13                     Mean time from admit to RRT =17 days; AKIN stage2(+shock)/3                                                                       Mean time from admit to AKIN stage 2(+shock)/3 but not dialyzed = 23 days                               6
  Carl2010                                                                                    US               Retrospective   Multisystem;Sepsis                44/85             42/62            Early: APACHE2=24.8;Late: APACHE2=24.7           Mean ICU stay prior to RRT = 6.3d;BUN \<100mg/dL + AKIN stage \>2;                                                                Mean ICU stay prior to RRT = 12.3d; BUN \> 100mg/dL + AKIN stage \>2;                                   7
  Hyung2012                                                                                   Korea            Retrospective   Multisystem                       75/105            81/105           Early: SOFA 14.4;Late: SOFA 14.4                 Time from ICU admission to RRT =4.7d                                                                                              Time from ICU admission to RRT =4.8d                                                                    7
  RRT initiated base on biochemical indicators; Meantime to initiation of RRT not specified                                                                                                                                                                                                                                                                                                                                                                                                    
  Kresse1999                                                                                  Germany          Retrospective   Multisystem                       83/141            102/128          NR                                               BUN≤34mmol/L, sCr 380umol/L, and urine output 924 ml/24h                                                                          BUN \>34mmol/L, sCr 477umol/L, and urine output 525 ml/24h                                              7
  Splendiani2001                                                                              Italy            Retrospective   Multisystem                       6/14              3/13             NR                                               BUN≤ 33mmol/L                                                                                                                     BUN\> 59 mmol/L and/or severe electrolyte disturbances                                                  5
  Tsai2005                                                                                    China            Retrospective   Multisystem                       42/67             30/31            NR                                               BUN\< 29 mmol/L                                                                                                                   BUN\> 29 mmol/L                                                                                         5
  Liu2006                                                                                     Multicountries   Prospective     Multisystem                       43/122            50/121           NR                                               Azotemia defined by BUN \< 76mg/dL                                                                                                Azotemia defined by BUN \> 76mg/dL                                                                      6
  Payen2009                                                                                   France           RCT             Multisystem                       20/37             17/39            Early: SOFA 11.6;Late: SOFA 10.4                 RRT × 96hrs w/diagnosis of 'sepsis'                                                                                               No RRT; unless metabolic renal failure & classic indications for RRT present                            M
  Elsevivrs2010                                                                               Belgium          Prospective     Multisystem                       379/653           280/650          Early: SOFA 9.9;Late: SOFA 8.5p=0.001            Serum Cr \>2mg/dL                                                                                                                 No RRT                                                                                                  5
  Konopka2011                                                                                 Poland           Retrospective   Multisystem                       17/25             11/12            NR                                               As soon as AKI was diagnosed                                                                                                      After full treatment for HF and unsuccessful pharmacological treatment of complicating AKI              5
  Chou2011                                                                                    China            Retrospective   Sepsis;Surgery ICU                135/192           124/178          Early: SOFA 10.8;Late: SOFA 11.6                 RIFLE criteria: RISK or pre-RISK                                                                                                  RIFLE criteria: INJURY or FAILURE                                                                       6
  Nascimento2012                                                                              Brazil           Retrospective   Multisystem                       9/23              43/63            Early: APACHE 2= 21;Late: APACHE 2= 28           BUN ≤26.7 mmol/L                                                                                                                  BUN\>26.7 mmol/L                                                                                        6
  Wu SC2012                                                                                   China            Retrospective   MultisystemSurgery                10/20             45/53            Early: SOFA 9.5;Late: SOFA 10.0                  RIFLE criteria: RISK                                                                                                              RIFLE criteria: INJURY or FAILURE                                                                       5
  Hu2013                                                                                      China            Retrospective   Multisystem                       20//36            8/13             Early: SOFA 9.3;Late: SOFA 11.5                  AKIN 1and 2 (Cr \>200-300%baseline &Urine\<0.5cc/kg/h for \>12h)                                                                  AKIN 3 (Cr ≥354μmol/L or Cr \>300% baseline & urine \<0.3cc/kg/h for 24h or anuria \>12h)               5
  Jamle2013                                                                                   India            RCT             Multisystem                       21/102            13/106           Early: SOFA 7.3;Late: SOFA 8.2                   Cr \>618μmol/L                                                                                                                    Traditional indications for RRT                                                                         M
  Gaudry2014                                                                                  France           Retrospective   Multisystem;Sepsis                44/91             29/112           Early: SOFA 9;Late: SOFA 8P\<0.01                RRT criteria: Cr ≥300μmol/L, Urea \>25mmol/L, K \>6.5mmol/L,pH \<7.2, Oliguria, Vol overload,                                     No RRT                                                                                                  5
  Tian(46^1^)2014                                                                             China            Retrospective   Multisystem;Sepsis                5/23              11/26            Early: SOFA 7.6;Late: SOFA 8.4                   AKIN 1 (Cr ≥26.4μmol/L or \>150- 200% baseline & urine \< 0.5cc/kg/h for \>6h)                                                    No RRT                                                                                                  6
  Tian(46^2^)2014                                                                             China            Retrospective   Multisystem;Sepsis                12/31             14/21            Early: SOFA 9.3;Late: SOFA 9.6                   AKIN 2 (Cr \>200-300% baseline &Urine \<0.5cc/kg/h for \>12h)                                                                     No RRT                                                                                                  6
  Tian(46^3^)2014                                                                             China            Retrospective   Multisystem;Sepsis                31/46             11/13            Early: SOFA 10;Late: SOFA 11.2                   AKIN 3 (Cr ≥354μmol/L or Cr \>300% baseline & urine \< 0.3cc/kg/h for 24h or anuria \>12h)                                        No RRT                                                                                                  6

LEGEN: AKI Acute kidney injury, RRT renal replacement therapy, Cr Creatinine, UOP Urine output, ICU Intensive Care Unit, AKIN Acute Kidney Injury Network, RIFLE Risk, Injury, Failure, Loss and End-stage, KDIGO Kidney Disease: Improving Global Outcomes, RCTs randomized clinical trials, Quality Score: The Cochrane Collaboration Risk of Bias tool for RCTs and Newcastle-Ottawa Scale for observational studies, H High quality: low risk of bias, M Medium quality: unclear risk of bias, L Low quality: high risk of bias, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, NR Not reported.

![Risk of bias summary of early versus late RRT initiation on mortality in patients with AKI on randomized controlled trial](oncotarget-08-68795-g002){#F2}

Meta-analysis results {#s2_2}
---------------------

### Primary outcomes {#s2_2_1}

Pooled analysis of 5408 critically ill patients with AKI showed that early RRT was markedly associated with reduced mortality compared to late RRT (OR, 0.40; 95% CI, 0.32 - 0.48; *I^2^*, 50.2%, Figure [3](#F3){ref-type="fig"}). For 4290 non-critically ill patients with AKI, there was no statistically significant difference in the risk of mortality between early and late RRT (OR, 1.07; 95% CI, 0.79 - 1.45; *I^2^*, 73.0%, Figure [3](#F3){ref-type="fig"}).

![Forest plot shows the effect of early versus late RRT on mortality in critically ill **(A)** and non-critically ill patients with AKI **(B)**.](oncotarget-08-68795-g003){#F3}

Subgroup analysis of critically ill patients was firstly conducted in the present study by using the definition of early according to time criteria versus biochemical indicators. The significant association between early RRT and reduced mortality was also found under the studies that defined early by time criteria \[early RRT within 12 hours (OR, 0.28; 95% CI, 0.16 - 0.49; *I^2^*, 44.8%), within 24 hours (OR, 0.37; 95% CI, 0.25 - 0.54; *I^2^*, 0.0%), within 48 hours (OR, 0.55; 95% CI, 0.39 - 0.77; *I^2^*, 30.8%), within 72 hours (OR, 0.45; 95% CI, 0.29 - 0.69; *I^2^*, 48.2%), and after 72 hours (OR, 0.32; 95% CI, 0.14 - 0.74; *I^2^*, 71.4%)\], and by biochemical parameters (OR, 0.40; 95% CI, 0.25 - 0.64; *I^2^*, 58.9%). Subgroup analysis of non-critically ill patients depending on the definition of early showed no significant subgroup survival benefits from early RRT.

Subgroup analysis of critically ill patients was based on the type of ICU admission. Early RRT was significantly associated with reduced mortality compared to late RRT among surgical group (OR, 0.33; 95% CI, 0.22 - 0.48; *I^2^*, 47.9%) and mixed group (OR, 0.43; 95% CI, 0.34 - 0.54; *I^2^*, 49.8%). Subgroup analysis of non-critically ill patients based on ICU admission type showed no evidence of survival advantage in early RRT.

Subgroup analysis of critically ill patients was also performed according to RRT modality \[continuous renal replacement therapy (CRRT), intermittent hemodialysis (IHD) or Mixed\]. We found a markedly significant reduce in mortality in critically ill patients assigned to early RRT in the CRRT group (OR, 0.40; 95% CI, 0.30 - 0.54; *I^2^*, 28.4%), IHD group (OR, 0.11; 95% CI, 0.03 - 0.43; *I^2^*, 56.9%) and Mixed group (OR, 0.45; 95% CI, 0.35 - 0.57; *I^2^*, 53.6%) when compared to late RRT. Subgroup analysis of non-critically ill patients according to RRT modality showed that early RRT could not confer a survival benefit (Table [2](#T2){ref-type="table"}).

###### Outcomes measures of early versus late RRT initiation

  Outcome or Subgroup                                                                                                 Group A: critically ill patients with AKI   Group B: non-critically ill patients with AKI                                                                                                                                                                                                
  ------------------------------------------------------------------------------------------------------------------- ------------------------------------------- ----------------------------------------------- --------------------------------------------------------------- ---------------------------- ------- ---- ------ ---------------------------------------------- ---------------------------- -------
  Primary Outcomes: early versus late RRT initiation on mortality                                                                                                                                                                                                                                                                                                                                              
  All studies                                                                                                         31                                          5408                                            7-9,12,18,28-30,32,34,35,38-41,43,44, 46^2^,46^3^,47,48,50-59   OR, 0.40 (0.32 to 0.48)      0.001   20   4290   10,11,13-17,19-23,31,33,36,37,42,45,46^1^,49   OR, 1.07 (0.79 to 1.45)      0.000
  Subgroup stratified by the definition of early according to time criteria and biochemical indicators on mortality                                                                                                                                                                                                                                                                                            
  Time: Early RRT \<12h                                                                                               7                                           639                                             9,12,28-30,32,56                                                OR, 0.28 (0.16 to 0.49)      0.093   5    1003   10,13,21,31,42                                 OR, 0.86 (0.58 to 1.29)      0.201
  Time: Early RRT \<24h                                                                                               4                                           534                                             34,35,53,54                                                     OR, 0.37 (0.25 to 0.54)      0.691   4    782    11,22,33,36                                    OR, 0.72 (0.43 to 1.19)      0.097
  Time: Early RRT \<48h                                                                                               3                                           1531                                            7,55,57                                                         OR, 0.55 (0.39 to 0.77)      0.236   3    368    17,19,37                                       OR, 0.82 (0.18 to 3.79)      0.012
  Time: Early RRT \<72h                                                                                               3                                           999                                             18,38,58                                                        OR, 0.45 (0.29 to 0.69)      0.145   1    28     16                                             OR, 36.0 (4.33 to 299.02)    NE
  Time: Early RRT \>72h                                                                                               4                                           465                                             8,39,40,52                                                      OR, 0.32 (0.14 to 0.74)      0.015   0    NE     NE                                             NE                           NE
  Biochemicl indicators                                                                                               10                                          1240                                            41,43,44, 46^2^,46^3^-48,50,51,59                               OR, 0.40 (0.25 to 0.64)      0.009   7    2109   14,15,20,23,45, 46^1^,49                       OR, 1.46 (0.96 to 2.23)      0.008
  Subgroup stratified by surgical versus mixed medical admissions on mortality                                                                                                                                                                                                                                                                                                                                 
  Surgical                                                                                                            9                                           1506                                            8,9,18,30,32,34,38,44,54                                        OR, 0.33 (0.22 to 0.48)      0.053   6    602    16,17,19,22,31,33                              OR, 0.71 (0.24 to 2.07)      0.000
  Mixed medical                                                                                                       22                                          3902                                            7,12,28,29,35,39,41,43,46^2^,46^3^-48,50-53,55-59               OR, 0.43 (0.34 to 0.54)      0.004   14   3688   10,11,13-15,20,21,23,36,37,42,45,46^1^,49      OR, 1.22 (0.91 to 1.63)      0.000
  Subgroup stratified by RRT modality on mortality                                                                                                                                                                                                                                                                                                                                                             
  Mixed                                                                                                               14                                          3442                                            7,9,12,28,29,35,38,41,43,48,53,54,55,57                         OR, 0.45 (0.35 to 0.57)      0.009   6    2495   13,14,20,21,45,49                              OR, 1.32 (0.86 to 2.03)      0.000
  CRRT                                                                                                                14                                          1771                                            8,18,32,34,39,40,44,46^2^,46^3^,47,50,52,55,58                  OR, 0.40 (0.30 to 0.54)      0.152   12   1544   10,11,15-17,22,31,33,36,37,42, 46^1^           OR, 0.92 (0.58 to 1.46)      0.017
  IHD                                                                                                                 3                                           255                                             30,51,59                                                        OR, 0.11 (0.03 to 0.43)      0.098   2    251    19,23                                          OR, 0.56 (0.04 to 8.73)      0.000
  Secondary outcomes: ICU and Hospital LOS                                                                                                                                                                                                                                                                                                                                                                     
  ICU LOS                                                                                                             8                                           862                                             28,34,35,38,41, 46^2^,46^3^,53                                  MD, −0.41 (−0.55 to −0.27)   0.000   4    336    17,19,31, 46^1^                                MD, −1.47 (−1.71 to −1.22)   0.000
  Hospital LOS                                                                                                        6                                           755                                             8,28,34,38,39,54                                                MD, −0.36 (−0.51 to −0.21)   0.000   3    287    17,19,31                                       MD, −1.07 (−1.31 to −0.82)   0.415

LEGEN: OR odds ratio, 95% CI confidence interval, *P* Test for Heterogeneity, MD mean difference, RRT renal replacement therapy, ICU Intensive Care Unit, CRRT continuous renal replacement therapy, IHD intermittent hemodialysis, Mixed CRRT and/or IHD and/or other RRT modality, LOS length of stay, NE not evaluable.

### Secondary outcomes {#s2_2_2}

For critically ill patients with AKI, as showed in Table [2](#T2){ref-type="table"}, early RRT significantly shortened ICU (MD, −0.41; 95% CI, −0.55 to −0.27; *I^2^*, 87.0%) and hospital LOS (MD, −0.36; 95% CI, −0.51 to −0.20; *I^2^*, 94.7%) compared to late RRT. Similar results were obtained in non-critically ill patients with AKI in ICU (MD, −1.47; 95% CI, −1.71 to −1.22; *I^2^*, 89.3%) and hospital LOS (MD, −1.07; 95% CI, −1.31 to −0.82; *I^2^*, 0%).

### Sensitivity, meta-regression analyses {#s2_2_3}

Statistically similar results were obtained after omitting each study of critically ill patients with AKI, and the results of the sensitivity analyses were robust. Sensitivity analyses showed that Elsevivrs et al. \[[@R20]\] was the main source of heterogeneity for the studies of non-critically ill patients with AKI, and the heterogeneity was significantly decreased by omitting the study. For non-critically ill patients with AKI, there was no statistically significant difference in the risk of mortality between early and late RRT with the study (OR, 1.07; 95% CI, 0.79 - 1.45; *I^2^*, 73.0%) or without the study (OR, 1.02; 95% CI, 0.74-1.40; *I^2^*, 66.8%). Elsevivrs et al. was a large sample trial with 1303 patients when compared to other articles including not more than 619 subjects (Figure [4](#F4){ref-type="fig"}).

![Sensitivity analyses of early versus late RRT on mortality in critically ill **(A)** and non-critically ill patients with AKI **(B)**.](oncotarget-08-68795-g004){#F4}

With the meta-regression, we did not find a correlation between patient mortality and study design (RCT *vs.* observational), RRT modality (CRRT, IHD *vs.* Mixed), study quality score, severity of illness \[Sequential Organ Failure Assessment (SOFA) score\], ICU admission type (surgical *vs.* mixed medical admissions). However, we find a correlation between patient mortality and sample size (n ≥ 100 *vs.* n \< 100, *P* = 0.001) in critically ill patients with AKI.

### Publication bias {#s2_2_4}

No potential publication bias was observed in non-critically ill patients with AKI (*P* = 0.347 for the Begg test, and *P* = 0.169 for the Egger test). Publication bias was seen in critically ill patients with AKI (*P* = 0.001 for the Begg test, and *P* = 0.000 for the Egger test, Figure [5](#F5){ref-type="fig"}).

![Begg's funnel plots of early versus late RRT on mortality in critically ill **(A)** and non-critically ill patients with AKI **(B)**.](oncotarget-08-68795-g005){#F5}

DISCUSSION {#s3}
==========

We identified 49 studies reported data on the timing of RRT initiation among 9698 patients with AKI, and we found that early RRT significantly reduced the mortality compared to late RRT in critically ill patients with AKI. In addition, no significant survival benefits associated with early RRT were seen in non-critically ill patients with AKI. Early RRT was markedly associated with shortened ICU and hospital LOS compared to late RRT in both critically ill and non-critically ill patients with AKI.

Regardless of the definition of early RRT (according to time criteria or biochemical indicators), ICU admission type (surgical *vs.* mixed) or RRT modality (CRRT, IHD *vs.* Mixed), subgroup analyses of critically ill patients with AKI did reveal survival benefits from early RRT. Furthermore, subgroup analyses of non-critically ill patients with AKI showed that no evidence of survival advantage in early RRT.

In the present study, we firstly performed the meta-analysis according to the severity of illness and definition of early RRT based on time-based cutoffs for patients with AKI to investigate the time of RRT initiation. We accepted a broad definition of "critically ill patients with AKI" based on AKI with multiple-organ dysfunction syndrome \[[@R60]\], septic shock \[[@R40]\], RIFLE criteria (failure, loss of function, and end-stage kidney disease) \[[@R37], [@R43], [@R44]\], AKIN stages 3 \[[@R41], [@R42], [@R46]\] or Kidney Disease: Improving Global Outcomes (KDIGO) stage 3 \[[@R12], [@R61]\].

By the meta-regression, we found sample size was one of the sources of heterogeneity. In contrast to previous meta-analyses, we found a lower heterogeneity among studies on this topic, especially in the subgroup. We noted those critically ill patients in early RRT within 12 hours (*I^2^*, 44.8%), 24 hours (*I^2^*, 0.0%), 48 hours (*I^2^*, 30.8%), and 72 hours (*I^2^*, 48.2%) showed the lower heterogeneities, indicating that the heterogeneity may be partially explained by the definition of early RRT timing. However, we could not account for the observed heterogeneity by meta-regression according to study design, RRT modality, the study quality score, severity of the illness, and ICU admission type. Thereby, the heterogeneity observed is most likely explained by the differences in definitions for early RRT timing, the inability to account for heterogeneity in clinical practice and critical care patterns, many confounding factors that affect the mortality, publication bias, sample size and the inclusion of retrospective, prospective and RCTs.

The present systematic review has some limitations. Firstly, definitions for AKI are to some extent different in the included studies. Secondly, the definition of early RRT based on various arbitrary cut-offs for time, which ultimately downgraded the strength of evidence. Thirdly, there were publication bias and significant heterogeneity in the present study. Many confounding factors affect the mortality, and meta-regression may not be enough to verify this issue. Lastly, the association with mortality is largely dependent on observational studies and might have been affected by allocation or selection bias. Thus, further high-quality RCTs focused on mortality according to the optimal time for starting RRT are necessary to fully understand the effects of early RRT for patients with AKI.

MATERIALS AND METHODS {#s4}
=====================

Participants, interventions and outcome measures {#s4_1}
------------------------------------------------

We included studies that evaluated the timing of initiation of RRT in patients with AKI. For the review, early and late RRT were defined based on criteria used by the authors in their studies. early and late RRT were defined as extended time-based cutoffs (arbitrary cut-offs for time from ICU admission or development of a biochemical "start time"), or biochemical indicators \[serum creatinine, serum urea, RIFLE (risk, injury, failure, loss of function, and end-stage kidney disease) classifications, Acute Kidney Injury Network (AKIN) stages, urine output, and fluid balance\]. Late RRT criteria also included conventional RRT indications (hyperkalemia, acidosis or fluid overload) and expectant care (no RRT initiated). The primary outcome was mortality, and the secondary outcomes were ICU and hospital LOS.

Searching strategies {#s4_2}
--------------------

We searched the Cochrane Library, EMBASE, Global Health, MEDLINE, PubMed, the International Clinical Trials Registry Platform, and Web of Science from January 1985 to November 2016. Owing to a low likelihood of relevance to modern RRT and critical care practices, studies published before 1985 were excluded in the present study. Keywords include acute renal failure/acute kidney injury/renal insufficiency, mortality, renal replacement therapy/renal dialysis/hemodialysis/dialysis. The related research references were also reviewed.

Inclusion and exclusion criteria {#s4_3}
--------------------------------

The inclusion criteria were as follows: (1) randomized clinical trials (RCTs) and/or observational cohort studies; (2) studies evaluating the timing of initiation of RRT in patients with AKI with direct effect on mortality; (3) complete data available to calculate odds ratio (OR) or mean difference (MD) with 95% confidence interval (CI); (4) clear definitions of AKI stated. Exclusion criteria were as follows: (1) data from the studies could not be extracted and analyzed; (2) duplicate publications; (3) non-human experimental studies.

Study selection and data extraction {#s4_4}
-----------------------------------

Two investigators (Kaiping Luo and Shufang Fu) independently performed the study selection. All the disagreements were resolved by discussion. Data extraction included first author, year of publication, country, study design, sample size, age, sex, RRT modality, mortality, ICU LOS, hospital LOS, and definitions of early and late RRT.

Dr. Gaudry and colleagues \[[@R13]\] showed that the mortality was lower in the patients who never received RRT than those received RRT early or late. Patients who received RRT late were the most severely ill at baseline, and patients who never received it were less ill at baseline. More than 50% mortality in critically ill patients with AKI received RRT was confirmed by many randomized controlled trials \[[@R1], [@R3], [@R4], [@R60]\]\]. Thus, we hypothesized that critically ill patients with AKI who receive early RRT may decrease mortality, non-critically ill patients with AKI may confer survival benefits without early RRT. Subjects were identified as being of "critically ill patients" if the late RRT group with high mortality rates (≥ 50%), or "non-critically ill patients" if the late RRT group with low mortality rates (\< 50%).

Quality assessment {#s4_5}
------------------

The Cochrane Collaboration Risk of Bias tool was used to assess RCTs \[[@R62]\]. This tool consists of 6 domains and assesses 5 specific biases. A judgment of low risk, unclear risk, or high risk was provided for each domain. The Newcastle-Ottawa Scale (NOS) was used in the assessment of quality of cohort studies \[[@R63]\]. NOS quality assessment scale ranges from 0 to 9 stars. The star evaluates 3 main categories: selection, comparability, and outcome.

Statistical analysis {#s4_6}
--------------------

Statistical analysis was performed using Review Manager (version 5.3) and STATA statistical software (version 12.0). We calculated OR with 95% CI for dichotomous data and MD with 95% CI for continuous data. Statistical heterogeneity of the data was quantified using the *I^2^* test, and the *I^2^*\> 50% indicated significant statistical heterogeneity. Sensitivity analysis, meta-regression analyses and subgroup analysis were conducted to investigate the potential sources of heterogeneity. Publication bias was assessed by constructing a funnel plot and using the Egger regression test and the Begg rank correlation test. A *P* value less than 0.05 was considered statistically significant.

CONCLUSIONS {#s5}
===========

Our data suggest that early RRT probably reduce the mortality, ICU and hospital LOS in critically ill patients with AKI. Inversely, early RRT in non-critically ill patients with AKI did not decrease the mortality, but shorted the ICU and hospital LOS.
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:   renal replacement therapy

AKI

:   acute kidney injury

OR

:   odds ratio

CI

:   confidential intervals
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:   risk, injury, failure, loss of function, and end-stage kidney disease
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RCTs

:   randomized clinical trials

MD
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:   continuous renal replacement therapy

IHD

:   intermittent hemodialysis
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:   Sequential Organ Failure Assessment
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:   Kidney Disease: Improving Global Outcomes
